• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Acceleron Pharma, Inc. (XLRN)

    -NasdaqGM
    40.63 Down 0.37(0.90%) 4:00PM EST
    |After Hours : 40.63 Down 0.00 (0.01%) 4:39PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 57,230   15,254   80,911  
    Cost of Revenue -   -  1,500  
    Gross Profit 57,230   15,254   79,411  
    Operating Expenses
    Research Development36,051  35,319  32,713  
    Selling General and Administrative14,227  8,824  8,142  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 6,952   (28,889) 38,556  
    Income from Continuing Operations
    Total Other Income/Expenses Net(26,758)(2,164)(468)
    Earnings Before Interest And Taxes(19,806)(31,053)38,088  
    Interest Expense2,092  1,529  1,822  
    Income Before Tax(21,898)(32,582)36,266  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(21,898)(32,582)36,266  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (21,898) (32,582) 36,266  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (21,898) (32,582) 36,266  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.